Wear OS watches might soon have an edge when it comes to blood oxygen
Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS smartwatches. That’s pretty inside baseball for the wearable industry, but it takes an interesting turn when you realize Masimo is also the reason why the new Apple Watch Series 10 doesn’t have blood oxygen features in the US.
Google taps Apple Watch nemesis Masimo for exclusive Wear OS health upgrades
Courts blocked Apple from enabling blood oxygen sensors in the Apple Watch due to patent infringement on medical device company Masimo, which holds over 1,500 medical technology patents. Google has now partnered with Masimo and Qualcomm to create health-focused Wear OS reference platforms,
After Forcing Apple Watch Ban, Masimo Now Partners with Google for Health Features
Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health tracking.
Google teams with Masimo to revive wear OS smartwatch diversity
Will the new strategy work? The world of smartwatch technology is constantly evolving, and Google plays a key role in it. Although,
New Wear OS watches will get health upgrades from the company that almost got the Apple Watch banned
With the help of Google, Masimo, a health tech giant, is building a new reference platform with upgraded health tracking on Wear OS.
Hosted on MSN11mon
Masimo (MASI) Gets De Novo for Novel Oxygen Status Index ORi
Data from one study showed that the use of ORi monitoring to titrate oxygen rates reduced time spent with hyperoxia compared with the use of SpO2 alone. Masimo has introduced a new sensor line ...
FierceBiotech11h
Politan prevails in Masimo proxy fight, gaining 2 board seats and ousting CEO Joe Kiani
Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...
Business Wire25d
Masimo SET ® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact
Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals ... 4 – achieved with Masimo’s flagship RD SET ® sensors – through challenging conditions such as patient motion ...
medtechdive1d
Masimo proxy fight nears end as shareholder vote looms
Koffey was elected to Masimo’s board in June 2023 along with Politan-backed candidate Michelle Brennan, a former Johnson & Johnson executive. The hedge fund argued that Masimo’s $1 billion acquisition ...
Orange County Business Journal4d
Masimo to Hold Pivotal Shareholder Meeting
The future of an iconic Orange County medtech entrepreneur – who was once compared to Steve Jobs – is at stake this week.
Yahoo Finance25d
Masimo SET® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact
Before Masimo SET ® pulse oximetry, false alarm rates were high ... A peer-reviewed publication using appropriately standardized sensor application sites demonstrated that Masimo RD SET ...
medtechdive10h
Masimo investor claims proxy war win as CEO Kiani fails to retain board seat
Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.
SmartHouse4d
Masimo Slips In Google Qualcomm Oxygen Deal Ahead Of Brutal Court Fight
Finally, the explosive Masimo AGM is set down for next week but not before another fight in US Courts which Masimo executives ...
Yahoo Finance25d
Masimo SET® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact
2 With more than 100 studies demonstrating its ability to outperform other pulse oximetry technologies, 3 SET ® measures with industry-best SpO 2 accuracy specifications 4 – achieved with Masimo ...